Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

MaxCyte, Inc. Common Stock (MXCT)

Services-commercial Physical & Biological Research

https://www.maxcyte.com

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

9713 KEY WEST AVENUE,, SUITE 400
ROCKVILLE, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/05/2019

Market Cap

426,136,747

Shares Outstanding

103,580,000

Weighted SO

103,576,429

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

SGHT --.--%

CVRX --.--%

NPCE --.--%

RPID --.--%

CNMD --.--%

KIDS --.--%

SRDX --.--%

ITGR --.--%

LUNG --.--%

Beta

1.1480

Last Div

0.0000

Range

2.45-5.545

Chg

-0.0450

Avg Vol

492872

Mkt Cap

426136747

Exch

NASDAQ

Country

US

Phone

301 944 1700

DCF Diff

4.3008

DCF

-0.0058

Div Yield

0.0000

P/S

9.3777

EV Multiple

-9.7319

P/FV

1.9177

Div Yield %

0.0000

P/E

-11.9761

PEG

-0.6436

Payout

0.0000

Current Ratio

14.3093

Quick Ratio

13.4002

Cash Ratio

3.0560

DSO

36.7960

DIO

483.5955

Op Cycle

520.3915

DPO

41.3000

CCC

479.0915

Gross Margin

0.8147

Op Margin

-1.0170

Pretax Margin

-0.7797

Net Margin

-0.7797

Eff Tax Rate

-53.7928

ROA

-0.1409

ROE

-0.1552

ROCE

-0.1932

NI/EBT

1.0000

EBT/EBIT

0.7667

EBIT/Rev

-1.0170

Debt Ratio

0.0737

D/E

0.0837

LT Debt/Cap

0.0739

Total Debt/Cap

0.0773

Int Coverage

-20.1308

CF/Debt

-1.2227

Equity Multi

1.1366

Rec Turnover

9.9196

Pay Turnover

8.8378

Inv Turnover

0.7548

FA Turnover

1.3885

Asset Turnover

0.1807

OCF/Share

-0.2165

FCF/Share

-0.2426

Cash/Share

1.5035

OCF/Sales

-0.4985

FCF/OCF

1.1206

CF Coverage

-1.2227

ST Coverage

-25.8023

CapEx Coverage

-8.2892

Div&CapEx Cov

-8.2892

P/BV

1.9177

P/B

1.9177

P/S

9.3777

P/E

-11.9761

P/FCF

-16.7854

P/OCF

-18.7298

P/CF

-18.7298

PEG

-0.6436

P/S

9.3777

EV Multiple

-9.7319

P/FV

1.9177

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 02:00 MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director GlobeNewswire Inc. Jan 02, 02:00 MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director GlobeNewswire Inc. Jan 02, 02:00 MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director

Revenue Product Segmentation